Eton Pharmaceuticals, Inc. (ETON) › Operating IncomeEton Pharmaceuticals, Inc. (ETON) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2018: -$10.32M2019: -$18.60M2020: -$27.11M2021: -$1.50M2022: -$8.26M2023: -$1.19M2024: -$2.60M2025: -$844.0K-$844.0K2018Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$844.0K+67.5%2024-$2.60M-117.9%2023-$1.19M+85.6%2022-$8.26M-452.5%2021-$1.50M+94.5%2020-$27.11M-45.8%2019-$18.60M-80.2%2018-$10.32M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share